These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
37. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents. Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865 [TBL] [Abstract][Full Text] [Related]
38. A comparison of masking effects of haloperidol versus molindone in tardive dyskinesia. Glazer WM; Hafez H Schizophr Res; 1990; 3(5-6):315-20. PubMed ID: 1980827 [TBL] [Abstract][Full Text] [Related]
39. Anticholinergic challenge and neuroleptic withdrawal. Changes in dyskinesia and symptom measures. Gardos G; Cole JO; Rapkin RM; LaBrie RA; Baquelod E; Moore P; Sovner R; Doyle J Arch Gen Psychiatry; 1984 Nov; 41(11):1030-5. PubMed ID: 6149737 [TBL] [Abstract][Full Text] [Related]
40. Skin conductance responding in schizophrenic patients with abnormal involuntary movements. Mintz M; Alfisi S; Sigal M Psychiatry Res; 1990 Oct; 34(1):19-27. PubMed ID: 1980017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]